Cargando…
A Novel Oxidovanadium (IV)-Orotate Complex as an Alternative Antidiabetic Agent: Synthesis, Characterization, and Biological Assessments
Diabetes is an increasingly common metabolic disorder with high comorbidity and societal and personal costs. Insulin replacement therapy is limited by a lack of oral bioavailability. Recent studies suggest vanadium has therapeutic potential. A newly synthesized complex between oxidovanadium (IV) and...
Autores principales: | Naglah, Ahmed M., Al-Omar, Mohamed A., Almehizia, Abdulrahman A., Bhat, Mashooq A., Afifi, Walid M., Al-Wasidi, Asma S., Al-Humaidi, Jehan Y., Refat, Moamen S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323442/ https://www.ncbi.nlm.nih.gov/pubmed/30671472 http://dx.doi.org/10.1155/2018/8108713 |
Ejemplares similares
-
Synthesis, Characterization, and Anti-diabetic Activity of Some Novel Vanadium-Folate-Amino Acid Materials
por: M. Naglah, Ahmed, et al.
Publicado: (2020) -
Synthesis of a vanadyl (IV) folate complex for the treatment of diabetes: spectroscopic, structural, and biological characterization
por: Naglah, Ahmed M, et al.
Publicado: (2019) -
Isolation and Bioassay of a New Terminalone A from Terminalia arjuna
por: Bushra,, et al.
Publicado: (2023) -
Synthesis of a new insulin-mimetic anti-diabetic drug containing vitamin A and vanadium(IV) salt: Chemico-biological characterizations
por: Adam, Abdel Majid A, et al.
Publicado: (2017) -
Novel sulindac derivatives: synthesis, characterisation, evaluation of antioxidant, analgesic, anti-inflammatory, ulcerogenic and COX-2 inhibition activity
por: Bhat, Mashooq A., et al.
Publicado: (2020)